Morgan Stanley stock trades near $194.92 support as weak momentum weighs

Traders Union
All News
Stocks
Morgan Stanley drops 3.8% to $198.29

Highlights

Morgan Stanley, Goldman Sachs, and JPMorgan are lead underwriters for Oura’s planned Nasdaq IPO, which is expected to generate incremental underwriting fees for Morgan Stanley.
Participation in high-profile IPOs helps Morgan Stanley maintain its capital markets business pipeline despite ongoing pressure on investment banking revenues.
Morgan Stanley stock fell 3.8% to $198.29, trades below key moving averages with high probability of a move lower toward $194.92 in the short term.

Deal pipeline expansion as Oura IPO drives fee prospects

Morgan Stanley is acting as one of the lead underwriters for Oura's planned IPO on the Nasdaq, together with Goldman Sachs and JPMorgan, according to Crypto. This engagement is expected to generate incremental fee revenue for MS and highlights the firm's ongoing role in capital markets dealmaking. Participation in prominent listings like Oura's helps replenish the investment banking deal pipeline, though price action has remained under broader selling pressure.

Mixed signals as overbought momentum clashes with weak price action

MS is trading below both its MA-20 at $203.83 and MA-50 at $206.18, with support anchored by the MA-200 at $193.14. The Ichimoku Kijun sits at $204.19, defining immediate resistance. Technical indicators are mixed: MACD and ADX are neutral, RSI is in buy territory at 57.57, and the Awesome Oscillator is in buy mode, but Stochastic RSI, CCI, and Bull/Bear Power all confirm overbought conditions, highlighting short-term upside exhaustion. Bull/Bear Power is also showing that buyers dominate intraday momentum, but the low-volatility move and close near the daily low underscore internal divergence between positive momentum readings and weak price action.

Downside risk heightened as resistance limits breakout potential

In the short term, the expected trading range is $194.92 to $205.24 as defined by recent volatility. Upward breakout potential is limited unless the price can close above resistance at $204.19, while a drop below $194.92 would likely accelerate a new leg lower. The baseline scenario anticipates consolidation between these levels, with a much higher probability of a downward extension than a sustained advance.

Viktoras Karapetjanc, expert at Traders Union, sees ongoing institutional activity as a key positive for Morgan Stanley. He notes that participation in the Oura IPO supports future fee revenue despite technical weakness and mixed short-term sentiment. While the current trading range points to possible further downside, he remains constructive given the firm’s active role in capital markets. "If buyers reclaim $204.19, tactical upside may resume — but structural momentum favors patient accumulation by fundamental investors."

Earlier, analysts noted that Morgan Stanley faced persistent downward momentum and technical pressures that limited the probability of an immediate recovery. The current analysis adds that despite the firm's participation in high-profile capital markets deals, price action remains vulnerable, with traders advised to monitor the $194.92 support level as a potential trigger for further downside risk.

Source of Data: MS Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.